• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION UNKNOWN OPTEASE VENA CAVA FILTER; FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION UNKNOWN OPTEASE VENA CAVA FILTER; FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Catalog Number 466FXXXX
Device Problem Fracture (1260)
Patient Problem Anxiety (2328)
Event Date 04/30/2021
Event Type  Injury  
Manufacturer Narrative
As reported by the legal brief, a patient underwent placement of an optease vena cava filter.The filter subsequently malfunctioned and caused injury and damage to the patient, including, but not limited to, fracture.Per the medical records provided, the patient was reported to be three weeks postpartum primary c-section; presented with right leg pain and was found to have extensive deep venous thrombosis (dvt), bilateral pulmonary embolism (pe) and a urinary tract infection (uti).The patient was started on lovenox but experienced shortness of breath, and it was felt that the patient could be likely experiencing recurrent pe; for that reason, the patient underwent placement of the inferior vena cava (ivc) filter and a mechanical thrombectomy with angiojet.About fourteen years and two months after the filter was implanted, the patient underwent a kidney, ureter and bladder (kub) x-ray.A clinical history of renal stones was noted at the time.The kub reported a fractured ivc filter and a displaced tubal ligation clip.According to the information received in the patient profile form (ppf), the patient reports fractured filter struts retained within the ivc, becoming aware of these events approximately fourteen years and two months after the filter implantation, and further experienced anxiety related to the filter.The device was not returned for analysis.No lot number was provided therefore a product history record (phr) review could not be generated.The reported ¿filter-fractured - in patient and anxiety¿ could not be confirmed as the device was not returned for analysis.The exact cause of the reported events could not be conclusively determined.Procedural/handling factors, or vessel characteristics, although unknown, may have contributed to the reported events.According to the ifu, which is not intended as a mitigation of risk, filter fracture is a potential complication of vena cava filters.Anatomic locations that create concentrated stress points from filter deformation (for example, deployment at apex of scoliosis, overlapping of either of the renal ostia, or placement adjacent to a vertebral osteophyte) may contribute to fracture of a particular filter strut.However, reports of adverse clinical sequelae from filter fractures are rare.Without images available for review, the reported events could not be confirmed or further clarified.Anxiety does not represent a device malfunction and may be related to underlying patient specific issues.Since no lot number was provided a phr could not be generated.The limited information available does not suggest a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.Should additional information become available, the file will be updated accordingly.
 
Event Description
As reported by the legal brief, a patient underwent placement of an optease vena cava filter.The filter subsequently malfunctioned and caused injury and damage to the patient, including, but not limited to fracture.Per the medical records provided, the patient was reported to be three weeks postpartum primary c-section; presented with right leg pain and was found to have extensive deep venous thrombosis (dvt), bilateral pulmonary embolism (pe) and a urinary tract infection (uti).The patient was started on lovenox but experienced shortness of breath, and it was felt that the patient could be likely experiencing recurrent pe; for that reason, the patient underwent placement of the ivc filter and a mechanical thrombectomy with angiojet.About fourteen years and two months after the filter was implanted, the patient underwent a kidney, ureter and bladder (kub) x-ray.A clinical history of renal stones was noted at the time.The kub reported a fractured ivc filter and a displaced tubal ligation clip.According to the information received in the patient profile form (ppf), the patient reports fractured filter struts retained within the inferior vena cava (ivc), becoming aware of these events approximately fourteen years and two months after the filter implantation, and further experienced anxiety related to the filter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN OPTEASE VENA CAVA FILTER
Type of Device
FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL 33014 2802
Manufacturer (Section G)
CORDIS CORPORATION
14201 nw 60th ave
miami lakes FL 33014 2802
Manufacturer Contact
karla castro
14201 nw 60th ave
miami lakes, FL 33014-2802
7863138372
MDR Report Key12259631
MDR Text Key264711828
Report Number1016427-2021-05205
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K034050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Other
Type of Report Initial
Report Date 08/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/02/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number466FXXXX
Was Device Available for Evaluation? No
Date Manufacturer Received07/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age41 YR
-
-